Jaguar Health (JAGX) Operating Expenses (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Operating Expenses data on file, last reported at $10.1 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $10.1 million, down 13.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.9 million (up 28.18% YoY), and the FY2025 annual result was $57.4 million, up 35.04% from the prior year.
• Operating Expenses eased to $10.1 million in Q1 2026 per JAGX's latest filing, from $24.5 million in the prior quarter.
• Over five years, Operating Expenses peaked at $24.5 million in Q4 2025 and troughed at $9.4 million in Q2 2022.
• A 5-year average of $11.8 million and a median of $10.8 million in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses declined 26.01% in 2022, then jumped 109.81% in 2025.
• A 5-year view of Operating Expenses shows it stood at $9.5 million in 2022, then rose by 3.26% to $9.9 million in 2023, then climbed by 18.35% to $11.7 million in 2024, then jumped by 109.81% to $24.5 million in 2025, then plunged by 58.78% to $10.1 million in 2026.
• Business Quant data shows JAGX's Operating Expenses at $10.1 million in Q1 2026, $24.5 million in Q4 2025, and $10.3 million in Q3 2025.